{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T11:43:48Z","timestamp":1793447028012,"version":"4.5.0"},"reference-count":46,"publisher":"American Chemical Society (ACS)","issue":"8","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA262153"],"award-info":[{"award-number":["R01CA262153"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R21CA288922"],"award-info":[{"award-number":["R21CA288922"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ascites fluid is a clinically relevant biological matrix commonly present in patients with high-grade serous ovarian carcinoma (HGSOC). Enrichment or depletion methods are required to compress the dynamic range of the ascites fluid proteome prior to mass spectrometry (MS)-based proteomic analysis. In this study, we evaluated the ability of Nanotrap Protein Enrichment Affinity Kits (PEAK) to enable the MS detection of lower-abundance proteins in ascites fluid in a biomarker discovery workflow. Nanotrap PEAK contains magnetic hydrogel nanoparticles (A, B, and C), whose complementary chemistries selectively isolate low-abundance proteins while excluding high-abundance proteins to enhance the depth of proteome coverage. The Nanotrap particles have previously been evaluated for plasma, serum, CSF, and urine protein enrichment but not ascites fluid. The use of the Nanotrap particles resulted in &amp;gt;2\u20133\u00d7 more identified proteins than the Neat ascites. An average of 61% of the proteins were enriched by the Nanotrap particles, whereas 39% were depleted. The maximum number of proteins identified among 10 HGSOC-derived ascites samples processed using the Nanotrap particles was 3480\u20134000 vs 1505 in the Neat samples. The use of Nanotrap particles is a cost-efficient and readily scalable approach for MS-based proteomic biomarker discovery studies in ascites fluid.<\/jats:p>","DOI":"10.1021\/acs.jproteome.6c00202","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T13:50:53Z","timestamp":1783777853000},"page":"4322-4332","source":"Crossref","is-referenced-by-count":2,"title":["Protein Enrichment\nfrom Ascites Fluid Using Nanotrap\nHydrogel Particle Technology"],"prefix":"10.1021","volume":"25","author":[{"given":"Carly A. I.","family":"Twigg","sequence":"first","affiliation":[{"name":"University of Minnesota , , , ,","place":["Minneapolis, Minnesota, United States, 55455"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Madden","sequence":"additional","affiliation":[{"name":"University of Minnesota , , , ,","place":["Minneapolis, Minnesota, United States, 55455"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin L. M.","family":"Boylan","sequence":"additional","affiliation":[{"name":"University of Minnesota , , , ,","place":["Minneapolis, Minnesota, United States, 55455"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy P. N.","family":"Skubitz","sequence":"additional","affiliation":[{"name":"University of Minnesota , , , ,","place":["Minneapolis, Minnesota, United States, 55455"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1679-5453","authenticated-orcid":true,"given":"Stefani N.","family":"Thomas","sequence":"additional","affiliation":[{"name":"University of Minnesota , , , ,","place":["Minneapolis, Minnesota, United States, 55455"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"issue":"10","key":"2026080709090058000_cit1","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nrc3144","article-title":"Rethinking ovarian cancer: recommendations\nfor improving outcomes","volume":"11","author":"Vaughan","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"2026080709090058000_cit2","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1002\/cncr.32004","article-title":"Critical questions in ovarian cancer research\nand treatment: Report of an American Association for Cancer Research\nSpecial Conference","volume":"125","author":"Bast","year":"2019","journal-title":"Cancer"},{"issue":"8","key":"2026080709090058000_cit3","doi-asserted-by":"publisher","first-page":"512","DOI":"10.6004\/jnccn.2024.0052","article-title":"NCCN Guidelines\u00ae Insights: Ovarian Cancer\/Fallopian\nTube Cancer\/Primary Peritoneal Cancer, Version 3.2024","volume":"22","author":"Liu","year":"2024","journal-title":"J. Natl. Compr. Cancer Network"},{"issue":"4","key":"2026080709090058000_cit4","doi-asserted-by":"publisher","first-page":"549","DOI":"10.21873\/cgp.20280","article-title":"Deep Dive\non the Proteome of Human Body Fluids: A Valuable Data Resource for\nBiomarker Discovery","volume":"18","author":"Li","year":"2021","journal-title":"Cancer Genomics Proteomics"},{"key":"2026080709090058000_cit5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fonc.2013.00256","article-title":"Getting to know\novarian cancer ascites: opportunities\nfor targeted therapy-based translational research","volume":"3","author":"Ahmed","year":"2013","journal-title":"Front. Oncol."},{"issue":"5","key":"2026080709090058000_cit6","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/annonc\/mdl499","article-title":"Pattern and prognostic\nfactors in patients with malignant\nascites: a retrospective study","volume":"18","author":"Ayantunde","year":"2007","journal-title":"Ann. Oncol."},{"issue":"2","key":"2026080709090058000_cit7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00404-018-4952-9","article-title":"Malignant\nascites occurs most often in patients with high-grade serous papillary\novarian cancer at initial diagnosis: a retrospective analysis of 191\nwomen treated at Bayreuth Hospital, 2006\u20132015","volume":"299","author":"Krugmann","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"issue":"17","key":"2026080709090058000_cit8","doi-asserted-by":"publisher","first-page":"4318","DOI":"10.3390\/cancers13174318","article-title":"Malignant\nAscites in\nOvarian Cancer: Cellular, Acellular, and Biophysical Determinants\nof Molecular Characteristics and Therapy Response","volume":"13","author":"Rickard","year":"2021","journal-title":"Cancers"},{"key":"2026080709090058000_cit9","doi-asserted-by":"publisher","first-page":"101755","DOI":"10.1016\/j.bbrep.2024.101755","article-title":"Ovarian cancer ascites proteomic profile\nreflects metabolic changes during disease progression","volume":"39","author":"Almeida-Nunes","year":"2024","journal-title":"Biochem. Biophys. Rep."},{"issue":"2","key":"2026080709090058000_cit10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ygyno.2007.10.018","article-title":"Correlation of NK T-like\nCD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and\nTNFalpha in ascites from advanced ovarian cancer: Association with\nplatinum resistance and prognosis in patients receiving first-line,\nplatinum-based chemotherapy","volume":"108","author":"Bamias","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"2026080709090058000_cit11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1525-1438.2006.00307.x","article-title":"Prognostic\nsignificance of vascular endothelial growth factor expression in ovarian\ncancer patients: a long-term follow-up","volume":"16","author":"Rudlowski","year":"2006","journal-title":"Int.\nJ. Gynecol. Cancer"},{"key":"2026080709090058000_cit12","volume-title":"BEST (Biomarkers,\nEndpointS,\nand other Tools) Resource","author":"Group, F.-N. B. W.","year":"2016"},{"key":"2026080709090058000_cit13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.clinbiochem.2018.04.003","article-title":"Comparative proteomic analysis of human malignant ascitic fluids\nfor the development of gastric cancer biomarkers","volume":"56","author":"Jin","year":"2018","journal-title":"Clin. Biochem."},{"issue":"5","key":"2026080709090058000_cit14","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1021\/pr1011087","article-title":"In-depth proteomics\nof ovarian cancer ascites: combining shotgun proteomics and selected\nreaction monitoring mass spectrometry","volume":"10","author":"Elschenbroich","year":"2011","journal-title":"J. Proteome\nRes."},{"issue":"1","key":"2026080709090058000_cit15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1021\/pr0703223","article-title":"A proteome resource\nof ovarian cancer ascites: integrated proteomic and bioinformatic\nanalyses to identify putative biomarkers","volume":"7","author":"Gortzak-Uzan","year":"2008","journal-title":"J.\nProteome Res."},{"issue":"4","key":"2026080709090058000_cit16","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1074\/mcp.M800313-MCP200","article-title":"Mining\nthe ovarian cancer ascites proteome for potential\novarian cancer biomarkers","volume":"8","author":"Kuk","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"issue":"12","key":"2026080709090058000_cit17","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1074\/mcp.M114.041194","article-title":"Proteome-metabolome profiling of ovarian cancer\nascites reveals novel components involved in intercellular communication","volume":"13","author":"Shender","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"issue":"1","key":"2026080709090058000_cit18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12943-025-02438-z","article-title":"Harnessing\novarian cancer ascites for translational\nscience: models, biomarkers, and therapeutics","volume":"24","author":"Dogra","year":"2025","journal-title":"Mol. Cancer"},{"issue":"1","key":"2026080709090058000_cit19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1039\/D0AN01701A","article-title":"Affinity-free enrichment and mass\nspectrometry analysis of the ovarian cancer biomarker CA125 (MUC16)\nfrom patient-derived ascites","volume":"146","author":"Schuster-Little","year":"2021","journal-title":"Analyst"},{"issue":"2","key":"2026080709090058000_cit20","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1021\/acs.jproteome.5c01103","article-title":"Proteomic\nStudies That Predict Patients\u2019 Responses to High-Grade Serous\nOvarian Cancer Treatments: A Systematic Review","volume":"25","author":"Scanlan","year":"2026","journal-title":"J. Proteome Res."},{"key":"2026080709090058000_cit21","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.202100372","article-title":"Differential\nhistone deacetylase\ninhibitor-induced perturbations of the global proteome landscape in\nthe setting of high-grade serous ovarian cancer","volume":"23","author":"Duda","year":"2023","journal-title":"Proteomics"},{"issue":"2","key":"2026080709090058000_cit22","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1021\/jasms.1c00215","article-title":"Proteomic Analysis\nReveals Low-Dose PARP Inhibitor-Induced Differential Protein Expression\nin BRCA1-Mutated High-Grade Serous Ovarian Cancer Cells","volume":"33","author":"Perez","year":"2022","journal-title":"J. Am. Soc. Mass Spectrom."},{"issue":"9","key":"2026080709090058000_cit23","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.3390\/molecules26092674","article-title":"Quantitative Mass\nSpectrometry-Based Proteomics for\nBiomarker Development in Ovarian Cancer","volume":"26","author":"Ryu","year":"2021","journal-title":"Molecules"},{"issue":"9","key":"2026080709090058000_cit24","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1074\/mcp.RA118.001221","article-title":"A Targeted Mass Spectrometry Strategy for Developing\nProteomic Biomarkers: A Case Study of Epithelial Ovarian Cancer","volume":"18","author":"Hu\u0308ttenhain","year":"2019","journal-title":"Mol. Cell. Proteomics"},{"issue":"18","key":"2026080709090058000_cit25","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1002\/pmic.201500004","article-title":"Applications\nof targeted proteomics in systems biology and translational medicine","volume":"15","author":"Ebhardt","year":"2015","journal-title":"Proteomics"},{"issue":"3","key":"2026080709090058000_cit26","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nchembio.2576","article-title":"How\nmany human proteoforms are there?","volume":"14","author":"Aebersold","year":"2018","journal-title":"Nat. Chem.\nBiol."},{"issue":"7518","key":"2026080709090058000_cit27","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nature13438","article-title":"Proteogenomic characterization of human colon and rectal cancer","volume":"513","author":"Zhang","year":"2014","journal-title":"Nature"},{"issue":"3","key":"2026080709090058000_cit28","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1021\/acs.jproteome.5b00859","article-title":"Reproducibility of Differential Proteomic Technologies\nin CPTAC Fractionated Xenografts","volume":"15","author":"Tabb","year":"2016","journal-title":"J. Proteome\nRes."},{"issue":"7","key":"2026080709090058000_cit29","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/s41596-018-0006-9","article-title":"Reproducible workflow\nfor multiplexed deep-scale\nproteome and phosphoproteome analysis of tumor tissues by liquid chromatography-mass\nspectrometry","volume":"13","author":"Mertins","year":"2018","journal-title":"Nat. Protoc."},{"issue":"7605","key":"2026080709090058000_cit30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature18003","article-title":"Proteogenomics\nconnects somatic mutations to\nsignalling in breast cancer","volume":"534","author":"Mertins","year":"2016","journal-title":"Nature"},{"issue":"10","key":"2026080709090058000_cit31","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1158\/2159-8290.CD-13-0219","article-title":"Connecting genomic alterations\nto cancer biology with proteomics: the NCI Clinical Proteomic Tumor\nAnalysis Consortium","volume":"3","author":"Ellis","year":"2013","journal-title":"Cancer Discovery"},{"key":"2026080709090058000_cit32","doi-asserted-by":"publisher","first-page":"5484976","DOI":"10.1155\/2018\/5484976","article-title":"Identification\nof Candidate Biomarkers in Malignant Ascites from Patients with Hepatocellular\nCarcinoma by iTRAQ-Based Quantitative Proteomic Analysis","volume":"2018","author":"Zhang","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"2026080709090058000_cit33","unstructured":"Nanosciences, C.\n          \n          App-217: nanotrap\nProtein Enrichment Affinity Kit Protocol; Manual Protein Enrichment\nFrom Plasma Samples, Cerebrospinal Fluid Samples, Or Urine Samples.https:\/\/www.ceresnano.com\/_files\/ugd\/0e8581_3be458080e4e4717a23861da6a871ac9.pdf."},{"issue":"12","key":"2026080709090058000_cit34","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1109\/TVCG.2014.2346248","article-title":"UpSet: Visualization\nof Intersecting Sets","volume":"20","author":"Lex","year":"2014","journal-title":"IEEE Trans. Vis. Comput.\nGraph."},{"issue":"9","key":"2026080709090058000_cit35","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","article-title":"The Perseus\ncomputational\nplatform for comprehensive analysis of (prote)omics data","volume":"13","author":"Tyanova","year":"2016","journal-title":"Nat. Methods"},{"issue":"D1","key":"2026080709090058000_cit36","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association\nnetworks and functional enrichment analyses for any sequenced genome\nof interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"2026080709090058000_cit37","unstructured":"Nanosciences, C.\n          \n          Nanotrap Protein\nEnrichment Affinity Kits For Protein Enrichment And Biomarker Discovery\nFrom Plasma Samples.https:\/\/www.ceresnano.com\/post\/nanotrap-protein-enrichment-affinity-kits-for-protein-enrichmentand-biomarker-discovery-from-plasma, 2024."},{"key":"2026080709090058000_cit38","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1021\/jasms.4c00131","article-title":"Evaluation of Serum Proteome Sample\nPreparation Methods to Support Clinical Proteomics Applications","volume":"35","author":"Twigg","year":"2024","journal-title":"J. Am. Soc. Mass Spectrom."},{"issue":"12","key":"2026080709090058000_cit39","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.1021\/acs.jproteome.1c00657","article-title":"Advances and Utility\nof the Human Plasma Proteome","volume":"20","author":"Deutsch","year":"2021","journal-title":"J. Proteome Res."},{"issue":"9","key":"2026080709090058000_cit40","doi-asserted-by":"publisher","first-page":"M110.006353","DOI":"10.1074\/mcp.M110.006353","article-title":"A high-confidence human plasma proteome reference set\nwith estimated concentrations in PeptideAtlas","volume":"10","author":"Farrah","year":"2011","journal-title":"Mol. Cell. Proteomics"},{"key":"2026080709090058000_cit41","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/978-1-61779-068-3_23","article-title":"Using the Human Plasma PeptideAtlas\nto study human plasma proteins","volume":"728","author":"Farrah","year":"2011","journal-title":"Methods Mol.\nBiol."},{"issue":"6","key":"2026080709090058000_cit42","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1200\/JCO.2003.02.022","article-title":"Human\nkallikrein 6 (hK6): a new potential serum biomarker for diagnosis\nand prognosis of ovarian carcinoma","volume":"21","author":"Diamandis","year":"2003","journal-title":"J. Clin.\nOncol."},{"issue":"11","key":"2026080709090058000_cit43","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1002\/pmic.201100005","article-title":"A systematic analysis of the effects\nof increasing degrees of serum immunodepletion in terms of depth of\ncoverage and other key aspects in top-down and bottom-up proteomic\nanalyses","volume":"11","author":"Smith","year":"2011","journal-title":"Proteomics"},{"issue":"13","key":"2026080709090058000_cit44","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf9717","article-title":"A simple, time- and\ncost-effective, high-throughput depletion strategy for deep plasma\nproteomics","volume":"9","author":"Viode","year":"2023","journal-title":"Sci. Adv."},{"key":"2026080709090058000_cit45","article-title":"Can an improved analytical depth in plasma proteomics\nprovide novel insights into COVID-19?","volume-title":"69th\nASMS Conference on Mass Spectrometry and Allied Topics","author":"Zecha","year":"2021"},{"issue":"D1","key":"2026080709090058000_cit46","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","article-title":"The PRIDE database at\n20 years: 2025 update","volume":"53","author":"Perez-Riverol","year":"2025","journal-title":"Nucleic Acids Res."}],"container-title":["Journal of Proteome Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jproteome.6c00202","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jprobs\/article-pdf\/25\/8\/4322\/65882760\/acs.jproteome.6c00202.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jprobs\/article-pdf\/25\/8\/4322\/65882760\/acs.jproteome.6c00202.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T13:12:34Z","timestamp":1786108354000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jprobs\/article\/25\/8\/4322\/5206924\/Protein-Enrichment-from-Ascites-Fluid-Using"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,7,11]]},"published-print":{"date-parts":[[2026,8,7]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jproteome.6c00202","relation":{},"ISSN":["1535-3893","1535-3907"],"issn-type":[{"value":"1535-3893","type":"print"},{"value":"1535-3907","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]}}}